The Experts below are selected from a list of 252 Experts worldwide ranked by ideXlab platform

Yaoshen Chen - One of the best experts on this subject based on the ideXlab platform.

  • orbital apex syndrome an unusual complication of Herpes Zoster Ophthalmicus
    BMC Infectious Diseases, 2015
    Co-Authors: Hungchin Tsai, Yaoshen Chen
    Abstract:

    Herpes Zoster Ophthalmicus is defined as Herpes Zoster involvement of the ophthalmic division of the trigeminal nerve. Ocular involvement occurs in 20–70% of patients with Herpes Zoster Ophthalmicus and may include blepharitis, keratoconjunctivitis, iritis, scleritis, and acute retinal necrosis. Orbital apex syndrome is a rare but severe ocular complication of Herpes Zoster Ophthalmicus. We present here the first reported case of Herpes Zoster Ophthalmicus complicated by orbital apex syndrome in a patient from Taiwan.

David T Vroman - One of the best experts on this subject based on the ideXlab platform.

  • Herpes Zoster Ophthalmicus presenting as giant cell arteritis
    Clinical and Experimental Ophthalmology, 2005
    Co-Authors: Luis Fernandez E De Castro, Aaron M Petersen, Syndee J Givre, Kerry D Solomon, David T Vroman
    Abstract:

    : A 74-year-old woman was referred to the authors' clinic with a 1-week suspicion of giant-cell arteritis. Uncomplicated, bilateral temporal artery biopsies were performed 3 days after admission for therapy. Four hours after the procedure she developed vesicular lesions of the face compatible with Herpes Zoster Ophthalmicus. The temporal artery biopsy revealed perineural lymphocytic aggregation. Both giant-cell arteritis and Herpes Zoster Ophthalmicus form part of the differential diagnosis in elderly patients with headache. In such cases, clues from a temporal artery biopsy may aid in diagnosis of Herpes Zoster. In addition, the patient in this case developed the rash 10 days after onset of symptoms, which is rare as the average time from onset of symptoms to rash in Zoster is 3-5 days.

Y Pouliquen - One of the best experts on this subject based on the ideXlab platform.

  • oral acyclovir for Herpes Zoster Ophthalmicus
    Ophthalmology, 1992
    Co-Authors: T Hoangxuan, Ernest R Buchi, Carl P Herbort, Josette Denis, Pascale Frot, Sylvie Thenault, Y Pouliquen
    Abstract:

    BACKGROUND: Reports on the natural history of Herpes Zoster Ophthalmicus stress its high morbidity related to vicious scars on eyelids, ocular complications, and post-herpetic neuralgia. Early treatment with oral acyclovir is effective, but the optimal duration of treatment has not been defined. METHODS: The authors performed a bicentric, prospective, randomized, double-masked study of 86 patients with acute Herpes Zoster Ophthalmicus, within 72 hours of skin eruption, who received oral acyclovir (800 mg 5 times daily), either for 7 days (plus 7 days oral placebo) or for 14 days. All patients concomitantly received ophthalmic 3% acyclovir ointment; follow-up was at least 6 months. RESULTS: Statistical analyses of subjective symptoms, skin lesions, and ocular complications showed no significant differences between the groups, suggesting that a 7-day course of treatment was sufficient. Drug tolerance was good. Pooled data from both groups corroborated earlier reports that prompt treatment with oral acyclovir reduces the severity of the skin eruption, the incidence and severity of late ocular manifestations, and the intensity of postherpetic neuralgia. At 6 months, late ocular inflammatory complications were seen in 29.1% of our 86 patients, versus 50% to 71% of untreated patients described by others. Only 13% of our patients experienced post-herpetic neuralgia, which in no case required the use of analgesics. CONCLUSION: The authors believe it is not useful to prolong treatment with 800 mg of oral acyclovir 5 times daily for more than 7 days in Herpes Zoster Ophthalmicus. This study confirms the efficacy of oral acyclovir not only against skin lesions and ocular complications, but also against postherpetic neuralgia in Herpes Zoster Ophthalmicus.

Luis Fernandez E De Castro - One of the best experts on this subject based on the ideXlab platform.

  • Herpes Zoster Ophthalmicus presenting as giant cell arteritis
    Clinical and Experimental Ophthalmology, 2005
    Co-Authors: Luis Fernandez E De Castro, Aaron M Petersen, Syndee J Givre, Kerry D Solomon, David T Vroman
    Abstract:

    : A 74-year-old woman was referred to the authors' clinic with a 1-week suspicion of giant-cell arteritis. Uncomplicated, bilateral temporal artery biopsies were performed 3 days after admission for therapy. Four hours after the procedure she developed vesicular lesions of the face compatible with Herpes Zoster Ophthalmicus. The temporal artery biopsy revealed perineural lymphocytic aggregation. Both giant-cell arteritis and Herpes Zoster Ophthalmicus form part of the differential diagnosis in elderly patients with headache. In such cases, clues from a temporal artery biopsy may aid in diagnosis of Herpes Zoster. In addition, the patient in this case developed the rash 10 days after onset of symptoms, which is rare as the average time from onset of symptoms to rash in Zoster is 3-5 days.

Hungchin Tsai - One of the best experts on this subject based on the ideXlab platform.

  • orbital apex syndrome an unusual complication of Herpes Zoster Ophthalmicus
    BMC Infectious Diseases, 2015
    Co-Authors: Hungchin Tsai, Yaoshen Chen
    Abstract:

    Herpes Zoster Ophthalmicus is defined as Herpes Zoster involvement of the ophthalmic division of the trigeminal nerve. Ocular involvement occurs in 20–70% of patients with Herpes Zoster Ophthalmicus and may include blepharitis, keratoconjunctivitis, iritis, scleritis, and acute retinal necrosis. Orbital apex syndrome is a rare but severe ocular complication of Herpes Zoster Ophthalmicus. We present here the first reported case of Herpes Zoster Ophthalmicus complicated by orbital apex syndrome in a patient from Taiwan.